Future-Ready ADCs – Advanced Vial Solutions for Superior Stability and Performance
Day 1 Packaging & Device Innovation Stage
06/10/2026 15:15 - 15:40pm
Contributors
Diana Löber : Global Product Manager Specialty Vials and adaptiQ® - SCHOTT Pharma AG & Co. KGaA
Antibody-drug conjugates (ADCs) promise targeted, high-potency cancer treatment, but their complexity introduces significant challenges for ADC packaging, which must ensure product stability, safety, and efficacy throughout the drug’s lifecycle.
Whether it’s …… fogging of the lyophilized drug vials that threatens container closure integrity… light sensitivity that accelerates degradation… or the instability of liquid formulations that risks safety and efficacy… each step in process must rise to meet ADC’s packaging challenges.In this talk, Diana Löber will introduce advanced vial solutions of the EVERIC® family that are designed to address these most critical needs.